Clinical and Genetic Characteristics, Target Therapy Results in Children with Traps Syndrome (on Clinical Surveillance Data)
The complexity of diagnosing and predicting the course of TNF-receptor-associated periodic syndrome TRAPS determines the importance of studying the dependence of clinical manifestations on the variant of genetic mutation and the presence of modifier genes. We observed 5 children with an identified d...
Saved in:
Main Authors: | E. V. Antsiferova, T. V. Cherkashina, N. G. Wolf, I. Yu. Naumenko, E. A. Anikina, N. G. Kiseleva, N. Yu. Makarevskaya, T. E. Taranushenko, L. N. Antsiferova, E. Yu. Emelyanchik |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2021-09-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3064 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
by: M. S. Eliseev, et al.
Published: (2015-06-01) -
NLRP12-associated periodic syndrome: A description of the authors' own observation and an analysis of literature data
by: M. F. Dubko, et al.
Published: (2017-04-01) -
Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab
by: T. V. Sleptsova, et al.
Published: (2016-11-01) -
RELAPSING POLYCHONDRITIS IN RHEUMATOLOGY PRACTICE
by: N. P. Shilkina, et al.
Published: (2018-05-01) -
Development of the doctrine of auto-inflammatory diseases in the XXI century
by: E. S. Fedorov, et al.
Published: (2019-04-01)